275 related articles for article (PubMed ID: 14529727)
1. Intramuscular injection of 125I-botulinum neurotoxin-complex versus 125I-botulinum-free neurotoxin: time course of tissue distribution.
Tang-Liu DD; Aoki KR; Dolly JO; de Paiva A; Houchen TL; Chasseaud LF; Webber C
Toxicon; 2003 Oct; 42(5):461-9. PubMed ID: 14529727
[TBL] [Abstract][Full Text] [Related]
2. The rat Digit Abduction Score (DAS) assay: a physiological model for assessing botulinum neurotoxin-induced skeletal muscle paralysis.
Broide RS; Rubino J; Nicholson GS; Ardila MC; Brown MS; Aoki KR; Francis J
Toxicon; 2013 Sep; 71():18-24. PubMed ID: 23707612
[TBL] [Abstract][Full Text] [Related]
3. How muscles recover from paresis and atrophy after intramuscular injection of botulinum toxin A: Study in juvenile rats.
Shen J; Ma J; Lee C; Smith BP; Smith TL; Tan KH; Koman LA
J Orthop Res; 2006 May; 24(5):1128-35. PubMed ID: 16602109
[TBL] [Abstract][Full Text] [Related]
4. Bioprotection of tendon repair: adjunctive use of botulinum toxin A in Achilles tendon repair in the rat.
Ma J; Shen J; Smith BP; Ritting A; Smith TL; Koman LA
J Bone Joint Surg Am; 2007 Oct; 89(10):2241-9. PubMed ID: 17908902
[TBL] [Abstract][Full Text] [Related]
5. Intramuscular Botulinum Neurotoxin Serotypes E and A Elicit Distinct Effects on SNAP25 Protein Fragments, Muscular Histology, Spread and Neuronal Transport: An Integrated Histology-Based Study in the Rat.
Martin V; Carre D; Bilbault H; Oster S; Limana L; Sebal F; Favre-Guilmard C; Kalinichev M; Leveque C; Boulifard V; George C; Lezmi S
Toxins (Basel); 2024 May; 16(5):. PubMed ID: 38787077
[TBL] [Abstract][Full Text] [Related]
6. Globular chitosan prolongs the effective duration time and decreases the acute toxicity of botulinum neurotoxin after intramuscular injection in rats.
Sergeevichev DS; Krasilnikova AA; Strelnikov AG; Fomenko VV; Salakhutdinov NF; Romanov AB; Karaskov AM; Pokushalov EA; Steinberg JS
Toxicon; 2018 Mar; 143():90-95. PubMed ID: 29371111
[TBL] [Abstract][Full Text] [Related]
7. Retrograde transport of radiolabelled botulinum neurotoxin type A to the CNS after intradetrusor injection in rats.
Papagiannopoulou D; Vardouli L; Dimitriadis F; Apostolidis A
BJU Int; 2016 Apr; 117(4):697-704. PubMed ID: 25912438
[TBL] [Abstract][Full Text] [Related]
8. Comparative immunochemical characteristics of botulinum neurotoxin type A and its associated proteins.
Bryant AM; Cai S; Singh BR
Toxicon; 2013 Sep; 72():126-32. PubMed ID: 23811077
[TBL] [Abstract][Full Text] [Related]
9. Botulinum neurotoxin type A-cleaved SNAP25 is confined to primary motor neurons and localized on the plasma membrane following intramuscular toxin injection.
Cai BB; Francis J; Brin MF; Broide RS
Neuroscience; 2017 Jun; 352():155-169. PubMed ID: 28389376
[TBL] [Abstract][Full Text] [Related]
10. Distribution of the toxin following medial rectus muscular injection of botulinum toxin gel in rabbits.
Chen J; Mai G; Yu X; Yu H; Wu H; Lin X; Deng D; Kang Y
Yan Ke Xue Bao; 2005 Mar; 21(1):52-5. PubMed ID: 17162917
[TBL] [Abstract][Full Text] [Related]
11. Isolation of synaptotagmin as a receptor for types A and E botulinum neurotoxin and analysis of their comparative binding using a new microtiter plate assay.
Li L; Singh BR
J Nat Toxins; 1998 Oct; 7(3):215-26. PubMed ID: 9783260
[TBL] [Abstract][Full Text] [Related]
12. Long-Term Effects of Botulinum Toxin Complex Type A Injection on Mechano- and Metabo-Sensitive Afferent Fibers Originating from Gastrocnemius Muscle.
Caron G; Marqueste T; Decherchi P
PLoS One; 2015; 10(10):e0140439. PubMed ID: 26485650
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of the proteasome partially attenuates atrophy in botulinum neurotoxin treated skeletal muscle.
Houston FE; Hain BA; Dodd SL
Toxicon; 2018 Mar; 144():48-54. PubMed ID: 29407164
[TBL] [Abstract][Full Text] [Related]
14. [Use of botulinum neurotoxin therapy].
Mukai Y; Kaji R
Brain Nerve; 2011 Jul; 63(7):775-84. PubMed ID: 21747148
[TBL] [Abstract][Full Text] [Related]
15. Dramatic changes in muscle contractile and structural properties after 2 botulinum toxin injections.
Minamoto VB; Suzuki KP; Bremner SN; Lieber RL; Ward SR
Muscle Nerve; 2015 Oct; 52(4):649-57. PubMed ID: 25598004
[TBL] [Abstract][Full Text] [Related]
16. Immunological characterization of the subunits of type A botulinum neurotoxin and different components of its associated proteins.
Kukreja R; Chang TW; Cai S; Lindo P; Riding S; Zhou Y; Ravichandran E; Singh BR
Toxicon; 2009 May; 53(6):616-24. PubMed ID: 19673075
[TBL] [Abstract][Full Text] [Related]
17. Therapeutic efficacy of new botulinum toxin identified in CCUG 7968 strain.
An Y; Kim YJ; Kim CS; Yim H; Kim M; Lee EK; Oh HJ; Han JH; Yoo E; Kim S; Woo J; Moore ERB; Jung JY; Park W
Appl Microbiol Biotechnol; 2021 Dec; 105(23):8727-8737. PubMed ID: 34716460
[TBL] [Abstract][Full Text] [Related]
18. Botulinum Neurotoxin A injections influence stretching of the gastrocnemius muscle-tendon unit in an animal model.
Haubruck P; Mannava S; Plate JF; Callahan MF; Wiggins WF; Schmidmaier G; Tuohy CJ; Saul KR; Smith TL
Toxins (Basel); 2012 Aug; 4(8):605-19. PubMed ID: 23012650
[TBL] [Abstract][Full Text] [Related]
19. Effect of 3,4-diaminopyridine on rat extensor digitorum longus muscle paralyzed by local injection of botulinum neurotoxin.
Adler M; Macdonald DA; Sellin LC; Parker GW
Toxicon; 1996 Feb; 34(2):237-49. PubMed ID: 8711757
[TBL] [Abstract][Full Text] [Related]
20. In-Vivo Neutralization of Botulinum Neurotoxin Serotype E Using Rabbit Polyclonal Antibody Developed against BoNT/E Light Chain.
Rani S; Ponmariappan S; Sharma A; Kamboj DV; Jain AK
Protein Pept Lett; 2017; 24(6):495-502. PubMed ID: 28260503
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
